Stock Analysis

What CLIO Cosmetics Co.,Ltd's (KOSDAQ:237880) 27% Share Price Gain Is Not Telling You

KOSDAQ:A237880
Source: Shutterstock

Despite an already strong run, CLIO Cosmetics Co.,Ltd (KOSDAQ:237880) shares have been powering on, with a gain of 27% in the last thirty days. Looking back a bit further, it's encouraging to see the stock is up 91% in the last year.

After such a large jump in price, CLIO CosmeticsLtd may be sending very bearish signals at the moment with a price-to-earnings (or "P/E") ratio of 21.8x, since almost half of all companies in Korea have P/E ratios under 13x and even P/E's lower than 7x are not unusual. Nonetheless, we'd need to dig a little deeper to determine if there is a rational basis for the highly elevated P/E.

With its earnings growth in positive territory compared to the declining earnings of most other companies, CLIO CosmeticsLtd has been doing quite well of late. It seems that many are expecting the company to continue defying the broader market adversity, which has increased investors’ willingness to pay up for the stock. If not, then existing shareholders might be a little nervous about the viability of the share price.

See our latest analysis for CLIO CosmeticsLtd

pe-multiple-vs-industry
KOSDAQ:A237880 Price to Earnings Ratio vs Industry May 25th 2024
Want the full picture on analyst estimates for the company? Then our free report on CLIO CosmeticsLtd will help you uncover what's on the horizon.

Is There Enough Growth For CLIO CosmeticsLtd?

The only time you'd be truly comfortable seeing a P/E as steep as CLIO CosmeticsLtd's is when the company's growth is on track to outshine the market decidedly.

Retrospectively, the last year delivered an exceptional 112% gain to the company's bottom line. Pleasingly, EPS has also lifted 283% in aggregate from three years ago, thanks to the last 12 months of growth. So we can start by confirming that the company has done a great job of growing earnings over that time.

Turning to the outlook, the next three years should generate growth of 17% per annum as estimated by the seven analysts watching the company. Meanwhile, the rest of the market is forecast to expand by 19% each year, which is noticeably more attractive.

In light of this, it's alarming that CLIO CosmeticsLtd's P/E sits above the majority of other companies. Apparently many investors in the company are way more bullish than analysts indicate and aren't willing to let go of their stock at any price. Only the boldest would assume these prices are sustainable as this level of earnings growth is likely to weigh heavily on the share price eventually.

What We Can Learn From CLIO CosmeticsLtd's P/E?

The strong share price surge has got CLIO CosmeticsLtd's P/E rushing to great heights as well. It's argued the price-to-earnings ratio is an inferior measure of value within certain industries, but it can be a powerful business sentiment indicator.

We've established that CLIO CosmeticsLtd currently trades on a much higher than expected P/E since its forecast growth is lower than the wider market. When we see a weak earnings outlook with slower than market growth, we suspect the share price is at risk of declining, sending the high P/E lower. This places shareholders' investments at significant risk and potential investors in danger of paying an excessive premium.

The company's balance sheet is another key area for risk analysis. Take a look at our free balance sheet analysis for CLIO CosmeticsLtd with six simple checks on some of these key factors.

You might be able to find a better investment than CLIO CosmeticsLtd. If you want a selection of possible candidates, check out this free list of interesting companies that trade on a low P/E (but have proven they can grow earnings).

Valuation is complex, but we're helping make it simple.

Find out whether CLIO CosmeticsLtd is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.

View the Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.